These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 170740)

  • 21. [Concentration of heterogeneous leukocyte interferon].
    Solov'ev VD; Parfenov VV; Zubanova NA; Pokidysheva LN; Tkach TA
    Vopr Virusol; 1981; (6):720-4. PubMed ID: 6175114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular size heterogeneity of human leukocyte interferon.
    Chadha KC; Sclair M; Sulkowski E; Carter WA
    Biochemistry; 1978 Jan; 17(1):196-200. PubMed ID: 618543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon.
    Kuwata T; Fuse A; Morinaga N
    J Gen Virol; 1977 Oct; 37(1):195-8. PubMed ID: 199703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral effect of interferon covalently bound to sepharose.
    Ankel H; Chany C; Galliot B; Chevalier MJ; Robert M
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2360-3. PubMed ID: 4365374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a subspecies of mouse interferon cross-reactive on human cells and antigenically related to human leukocyte interferon.
    Stewart WE; Havell EA
    Virology; 1980 Feb; 101(1):315-8. PubMed ID: 6243831
    [No Abstract]   [Full Text] [Related]  

  • 26. Equine interferon: characterization of a viral inhibitor induced in equine kidney cell cultures with statolon.
    Ley KD; Burger D; Henson JB
    J Infect Dis; 1970 Mar; 121(3):335-8. PubMed ID: 4313279
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures.
    Weck PK; Apperson S; May L; Stebbing N
    J Gen Virol; 1981 Nov; 57(Pt 1):233-7. PubMed ID: 6172550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the suppression of cell and virus growth in transformed human cells of leukocyte and fibroblast interferon.
    Kuwata T; Fuse A; Suzuki N; Morinaga N
    J Gen Virol; 1979 May; 43(2):435-9. PubMed ID: 225426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of two distinct molecular populations of type I mouse interferons.
    Stewart WE; LeGoff S; Wiranowska-Stewart
    J Gen Virol; 1977 Nov; 37(2):277-84. PubMed ID: 200708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the antiviral and antiproliferative activity of human interferon preparations obtained in suspension and stationary cultures of donor leukocytes].
    Timofeev IV; Kuznetsov VP; Mekhedov LN; Nikolaeva TG; Orlova TG
    Antibiotiki; 1981 Sep; 26(9):703-5. PubMed ID: 6170254
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon production by individual cells.
    Rodgers R; Merigan TC
    Virology; 1974 Feb; 57(2):467-74. PubMed ID: 4361456
    [No Abstract]   [Full Text] [Related]  

  • 32. A convenient and rapid cytopathic effect inhibition assay for interferon.
    Familletti PC; Rubinstein S; Pestka S
    Methods Enzymol; 1981; 78(Pt A):387-94. PubMed ID: 6173617
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of interferon on transcription and translation of vesicular stomatitis virus in human and simian cell cultures.
    Thacore HR
    J Gen Virol; 1978 Nov; 41(2):421-6. PubMed ID: 214523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):512-22. PubMed ID: 4357054
    [No Abstract]   [Full Text] [Related]  

  • 35. SDS-polyacrylamide gel electrophoresis of purified human leucocyte interferon and the antiviral and anticellular activities of the different interferon species.
    Berg K; Heron I
    J Gen Virol; 1980 Oct; 50(2):441-6. PubMed ID: 6161993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
    Thacore HR; Youngner JS
    Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
    [No Abstract]   [Full Text] [Related]  

  • 37. [More rapid method of microtitration of murine interferons by retarding the cytopathogenic effect of vesicular stomatitis virus].
    Pavlushina SV; Orlova TG
    Vopr Virusol; 1981; (2):242-3. PubMed ID: 6168118
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative studies on the inhibitory effects of interferon on various strains of herpes simplex viruses in vitro.
    Imanishi J; Matsubara M; Kishida T; Ozaki Y; Kurimura T
    Biken J; 1980 Sep; 23(3):107-11. PubMed ID: 6161604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiviral activity of certain thiophosphate and 2'-chloro substituted polynucleotide homopolymer duplexes.
    Black DR; Eckstein F; Hobbs JB; Sternbach H; Merigan TC
    Virology; 1972 May; 48(2):537-45. PubMed ID: 4337034
    [No Abstract]   [Full Text] [Related]  

  • 40. Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.
    Gardner LJ; Vilcek J
    J Gen Virol; 1979 Jul; 44(1):161-8. PubMed ID: 227987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.